An Open Label Pilot Study of Feasibility of a Dexmedetomidine-Remifentanil-Caudal Anaesthetic for Infant Lower Abdominal/Lower Extremity Surgery: The TREX Pilot Study

Trial Profile

An Open Label Pilot Study of Feasibility of a Dexmedetomidine-Remifentanil-Caudal Anaesthetic for Infant Lower Abdominal/Lower Extremity Surgery: The TREX Pilot Study

Completed
Phase of Trial: Phase IV

Latest Information Update: 04 Nov 2016

At a glance

  • Drugs Dexmedetomidine (Primary) ; Remifentanil (Primary) ; Bupivacaine; Ropivacaine
  • Indications Anaesthesia
  • Focus Adverse reactions
  • Acronyms The TREX pilot study
  • Most Recent Events

    • 24 Oct 2016 Status changed from recruiting to completed.
    • 07 Sep 2016 Planned number of patients changed from 50 to 60.
    • 16 Mar 2016 Protocol amended as dose of dexmedetomidine changed (loading dose: 0.6 mcg/kg to 1mcg/kg, infusion from 0.1 mcg/kg/min- 0.2 mcg/kg/min) as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top